Detecting signaling effects of IL1R2 overexpression by CRISPRa with synthetic crRNAs
The CRISPR-Cas9 system has been adapted to up-regulate any gene in its endogenous context, enabling gain-of-function or gene activation experiments while avoiding the use of exogenous over-expression plasmids. CRISPR activation (CRISPRa) provides new tools to identify gene functions that might otherwise go undetected using loss-of-function studies through down-regulation of gene expression or gene knockout.
CRISPRa uses deactivated or “dead” Cas9 (dCas9), a mutant variant of the Cas9 protein that is nuclease-deficient due to mutations in the RuvCI and HNH domains1. Edit-R CRISPRa utilizes dCas9-VPR where the dCas9 is fused to three transcriptional activators VP64, p65, and Rta (VPR) on the C-terminus 2. Guide RNAs that target upstream of the transcriptional start site (TSS) of a desired gene can bind the dCas9-VPR and guide the complex to the DNA target site and enable up-regulation of the target gene. Dharmacon Edit-R CRISPRa guide RNA designs are based on a published CRISPRa v2 algorithm 3 and are different than the Edit-R guide RNAs which are optimized for functional gene knockout. The CRISPRa guide RNA can be either single guide RNA (sgRNA) or synthetic CRISPR RNA (crRNA) complexed with a trans-activating CRISPR RNA (tracrRNA) (Figure 1) enabling development of wide range of phenotypic assays for functional gene analysis.
Figure 1. Edit-R CRISPRa uses deactivated Cas9 (dCas9) fused to the transcriptional activators VP64, p65, and Rta (VPR), guided by crRNA:tracrRNA upstream of a transcriptional start site (TSS) to up-regulate expression of a target gene.
IL1R2 gene encodes for a cytokine receptor that belongs to the interleukin 1 receptor family. IL1R2 is a negative regulator of interleukin 1 (IL1) signaling in several ways (reviewed in 4). It is competing with interleukin 1 receptor, type I (IL1R1) for IL1 ligand and it complexes with interleukin 1 receptor accessory protein (IL1RAP), thereby sequestering both the ligand and the accessory protein required for signal transduction that leads to production of cytokines IL6 and IL8 5, 6, 7. Other studies have shown that IL1R2 plays role in regulation of cell morphology and migration and some of its functions are exuded through regulation of ZEB2 and GEMIN2 expression levels 8, 9 (Figure 2A).
In our study, we looked at downstream effects of IL1R2 transcriptional activation by CRISPRa in U2OS cells that stably express dCas9-VPR. IL1R2 is not expressed in U2OS cells, and upon transfection with an Edit-R CRISPRa crRNA pool (four individual synthetic crRNAs) targeting the promoter region we observe strong activation of more than 10,000 fold (Figure 2B). This IL1R2 upregulation leads to down-regulation of IL6 and IL8 (Figure 2C) and up-regulation of ZEB2 and GEMIN2 (Figure 2D), confirming literature predicted downstream gene effects and demonstrating that signaling of IL1R2 can be studied using CRISPRa.
Figure 2. A. Diagram showing predicted gene expression changes upon activation of IL1R2 from previous publications. B. U2OS cells stably expressing integrated dCas9-VPR were transfected with a synthetic crRNA pool complexed with tracrRNA (25 nM) targeting IL1R2 using DharmaFECT 4 transfection reagent. Gene activation of IL1R2 was assessed at 72 hours post transfection by RT-qPCR and is shown as fold transcriptional activation compared to non-targeting control (NTC) C. Relative expression of IL6 and IL8 upon CRISPRa of IL1R2 analyzed by RT-qPCR and normalized to NTC samples D. Relative expression of ZEB2 and GEMIN2 upon CRISPRa activation IL1R2 analyzed by RT-qPCR and normalized to NTC samples.
Authors: Eldon Chou, Maren Mayer Gross and Žaklina Strezoska
Get an overview of this powerful gain-of-function technology!
Find product guides, FAQs and more.